𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stereoselective Synthesis of Monoamine Reuptake Inhibitor NS9544 Acetate

✍ Scribed by Malmgren, Håkan; Cotton, Hanna; Frøstrup, Brian; Jones, David Spencer; Loke, Marie-Louise; Peters, Dan; Schultz, Sara; Sölver, Ellen; Thomsen, Tove; Wennerberg, Johan

Book ID
117999985
Publisher
American Chemical Society
Year
2011
Tongue
English
Weight
731 KB
Volume
15
Category
Article
ISSN
1083-6160

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of monoamine reuptake inhibitor N
Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease
✍ William Bara-Jimenez; Tzvetelina Dimitrova; Abdulah Sherzai; Antonella Favit; M. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

## Abstract Dopamine reuptake blockers, by enhancing and stabilizing intrasynaptic transmitter levels, could help palliate motor dysfunction in Parkinson's disease. This randomized, double‐blind, placebo‐controlled study compared the acute effects of the monoamine uptake inhibitor NS 2330 to those

Randomized trial of the triple monoamine
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease
✍ Robert A. Hauser; Laurence Salin; Nolwenn Juhel; Victor L. Konyago 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract The objective of this study was to evaluate the efficacy and safety of three daily dosages of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) compared to placebo as monotherapy in early Parkinson's disease (PD). In MPTP (1‐methyl 4‐phenyl‐tetrahydropyridine 1,2,3,6)‐lesion